Biocytogen is seeking a high-impact, early-career technology specialist to take ownership of critical digital systems that support our fast-growing CRO operations. As the IT & Digital Systems Integration Specialist, you will lead the design, implementation, and continuous improvement of our digital platforms—including CRM systems, analytics tools, new platform deployments, and cybersecurity protocols.
This is not a passive support role. You will be expected to drive integration projects, make technical decisions, and collaborate directly with business, science, and operational teams. You’ll be empowered to experiment, recommend tools, implement automation, and shape how we use technology to accelerate drug discovery.
If you're a self-starter with strong technical foundations, a problem-solving mindset, and a desire to make a visible impact in biotech, this is your opportunity to build and lead from the ground up.
1. New Platform and System Development / Implementation
2. IT Platform Integration
3. CRM Management & Data Analytics Support
4. AI & Automation Integration
5. Cybersecurity & IT Support
Requirements
Benefits
BIOCYTOGEN is an Equal Opportunity Employer. Employment opportunities at BIOCYTOGEN BOSTON CORP are based upon one’s qualifications and capabilities to perform the essential functions of a particular job. All employment opportunities are provided without regard to race, color religion, sex, national origin, ancestry, age, sexual orientation, gender identity and expression, veteran status, military status, disability, mental illness, genetic information, or any other characteristic protected by law. This Equal Employment Opportunity policy governs all aspects of employment, including, but not limited to, recruitment, hiring, selection, job assignment, promotions, transfers, compensation, discipline, termination, layoff, access to benefits and training, and all other conditions and privileges of employment.

Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMab™ mice), and in vivo/in vitro preclinical validation studies. Biocytogen collaborates with more than 70% of the top 50 pharmaceutical and biotechnology companies worldwide. Together, we discover innovative medicines for a better, healthier world.